SPRO Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Spero Therapeutics Inc

Watchlist Manager

Watchlist

Price: 1.04 USD

Market Cap: $60.6m

	Spero Therapeutics Inc NASDAQ:SPRO	US
V	Vinci SA F:SQUA	FR
C	Capstone Partners Co Ltd KOSDAQ:452300	KR
N	NewEn AI Co Ltd KOSDAQ:463020	KR
	Prada SpA F:PRP	IT
	Distribution Solutions Group Inc NASDAQ:DSGR	US
	Bollinger Innovations Inc F:1N5	US
E	Evoke PLC XMUN:C8V	GI
P	PICC Property and Casualty Co Ltd OTC:PPCCF	CN
S	Swiss Prime Site AG XMUN:SU1N	CH
J	Japan Post Bank Co Ltd F:5JP	JP
W	Weir Group PLC DUS:42W	UK
C	CMS Info Systems Ltd NSE:CMSINFO	IN

Profitability Summary

Spero Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Healthy Operating Margin

14%

Negative 3Y Average Operating Margin

-40%

Operating Margin is Increasing

3% > 14%

Healthy Net Margin

16%

Negative 3Y Average Net Margin

-37%

Net Margin is Increasing

-2% > 16%

Exceptional Free Cash Flow Margin

42%

Negative 3Y Average Free Cash Flow Margin

-27%

Free Cash Flow Margin is Increasing

37% > 42%

Positive ROE

19%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-20%

ROIC is Increasing

-48% > 41%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.